Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10108	Companies
207142	Keywords
137281	Articles
109791	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 09/27/2024 at 09:00, 1 year 6 months ago

Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases
Formycon and Fresenius Kabi secure European Commission approval for FYB202/Otulfi® (ustekinumab) to treat inflammatory diseases, expanding biosimilar portfolio

Biosimilar Formycon Fresenius Kabi Ustekinumab European Commission Approval
BRIEF

published on 09/17/2024 at 06:55, 1 year 6 months ago

Formycon to Present FYB202 Biosimilar Data at EADV Congress and UEG Week

Clinical Data Biosimilar Formycon FYB202 Ustekinumab
BRIEF

published on 09/17/2024 at 06:55, 1 year 6 months ago

Formycon présentera les données biosimilaires FYB202 au congrès EADV et à la semaine UEG

Formycon FYB202 Ustekinumab Biosimilaire Données Cliniques
PRESS RELEASE

published on 09/17/2024 at 06:50, 1 year 6 months ago

Formycon will present clinical data on its ustekinumab biosimilar candidate FYB202 at the EADV Congress in Amsterdam and the UEG Week in Vienna
Formycon to present clinical data on ustekinumab biosimilar FYB202 at EADV Congress in Amsterdam and UEG Week in Vienna. Biosimilar for psoriasis and IBD in final approval phase

Clinical Data Biosimilar Formycon Ustekinumab Approval Process
BRIEF

published on 08/19/2024 at 14:16, 1 year 7 months ago

First Berlin Equity Research Maintains Buy Rating for Formycon AG

BUY Rating Biosimilars Formycon Revenue Update H1/24 Results
BRIEF

published on 08/19/2024 at 14:16, 1 year 7 months ago

First Berlin Equity Research maintient sa note d'achat pour Formycon AG

Acheter Une Note Formycon Biosimilaires Résultats H1/24 Mise À Jour Des Revenus
PRESS RELEASE

published on 08/19/2024 at 14:11, 1 year 7 months ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Formycon AG (ISIN: DE000A1EWVY8) with H1/24 results, maintaining BUY rating and EUR 80 target price. Formycon raises FY/24 guidance due to stronger than expected results

First Berlin Equity Research BUY Rating Formycon AG H1/24 Results EUR 80 Target Price
BRIEF

published on 08/13/2024 at 06:55, 1 year 7 months ago

Formycon Reports Robust First Half-Year with Significant Milestones

Financial Results Biosimilars Clinical Milestones Formycon FYB201
BRIEF

published on 08/13/2024 at 06:55, 1 year 7 months ago

Formycon annonce un premier semestre solide avec des étapes importantes

Résultats Financiers Formycon Biosimilaires FYB201 Jalons Cliniques
PRESS RELEASE

published on 08/13/2024 at 06:50, 1 year 7 months ago

Formycon reports a strong first half-year with multiple milestones achieved
Formycon AG reports successful first half-year with key operational, clinical, and regulatory milestones achieved. Group revenue and EBITDA in line with expectations. Invitation to conference call today

Conference Call Revenue Formycon AG Milestones First Half-Year

Accesswire

Published on 03/28/2026 at 01:00, 2 hours 4 minutes ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 2 hours 9 minutes ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 2 hours 14 minutes ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 4 hours 19 minutes ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 4 hours 34 minutes ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property

View all ACCESSWIRE

EQS Group

Published on 03/28/2026 at 01:42, 1 hour 21 minutes ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 5 hours 5 minutes ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 5 hours 5 minutes ago

Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/27/2026 at 20:08, 6 hours 55 minutes ago

EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 7 hours 33 minutes ago

Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe

Les Echos

Published on 03/27/2026 at 19:06, 7 hours 57 minutes ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 7 hours 57 minutes ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 8 hours 11 minutes ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 8 hours 11 minutes ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025
Published on 03/27/2026 at 18:40, 8 hours 23 minutes ago

2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan

View all LES ECHOS COMFI WIRE